Metropolis Healthcare Future Growth
Future criteria checks 5/6
Metropolis Healthcare is forecast to grow earnings and revenue by 24.5% and 11.7% per annum respectively. EPS is expected to grow by 24.1% per annum. Return on equity is forecast to be 21.2% in 3 years.
Key information
24.5%
Earnings growth rate
24.1%
EPS growth rate
| Healthcare earnings growth | 27.7% |
| Revenue growth rate | 11.7% |
| Future return on equity | 21.2% |
| Analyst coverage | Good |
| Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09
Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 10Metropolis Healthcare (NSE:METROPOLIS) Knows How to Allocate Capital
Dec 26The Metropolis Healthcare (NSE:METROPOLIS) Share Price Is Up 54% And Shareholders Are Holding On
Dec 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 17,753 | 2,849 | 3,300 | N/A | 2 |
| 3/31/2026 | 15,237 | 2,268 | 2,961 | N/A | 13 |
| 3/31/2025 | 13,558 | 1,830 | 2,401 | N/A | 13 |
| 3/31/2024 | 11,888 | 1,351 | 1,742 | N/A | 12 |
| 12/31/2023 | 11,593 | 1,248 | N/A | N/A | N/A |
| 9/30/2023 | 11,536 | 1,334 | 1,718 | 2,183 | N/A |
| 6/30/2023 | 11,454 | 1,383 | N/A | N/A | N/A |
| 3/31/2023 | 11,482 | 1,429 | 1,945 | 2,471 | N/A |
| 12/31/2022 | 11,716 | 1,495 | N/A | N/A | N/A |
| 9/30/2022 | 11,792 | 1,548 | 1,754 | 2,266 | N/A |
| 6/30/2022 | 11,814 | 1,727 | N/A | N/A | N/A |
| 3/31/2022 | 12,283 | 2,142 | 2,226 | 2,533 | N/A |
| 12/31/2021 | 12,142 | 2,355 | N/A | N/A | N/A |
| 9/30/2021 | 11,959 | 2,531 | 2,924 | 3,195 | N/A |
| 6/30/2021 | 11,816 | 2,551 | N/A | N/A | N/A |
| 3/31/2021 | 9,980 | 1,831 | 2,208 | 2,490 | N/A |
| 12/31/2020 | 9,132 | 1,372 | N/A | N/A | N/A |
| 9/30/2020 | 8,613 | 1,207 | 1,756 | 2,059 | N/A |
| 6/30/2020 | 7,962 | 1,034 | N/A | N/A | N/A |
| 3/31/2020 | 8,564 | 1,273 | 1,788 | 2,150 | N/A |
| 12/31/2019 | 8,513 | 1,463 | N/A | N/A | N/A |
| 9/30/2019 | 8,189 | 1,355 | 1,020 | 1,341 | N/A |
| 6/30/2019 | 7,887 | 1,230 | N/A | N/A | N/A |
| 3/31/2019 | 7,612 | 1,201 | 664 | 902 | N/A |
| 3/31/2018 | 6,472 | 1,042 | 840 | 1,039 | N/A |
| 3/31/2017 | 5,447 | 1,017 | N/A | 1,018 | N/A |
| 3/31/2016 | 4,755 | 768 | N/A | 914 | N/A |
| 3/31/2015 | 4,555 | 610 | N/A | 695 | N/A |
| 3/31/2014 | 3,883 | 566 | N/A | 769 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: METROPOLIS's forecast earnings growth (24.5% per year) is above the savings rate (6.7%).
Earnings vs Market: METROPOLIS's earnings (24.5% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: METROPOLIS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: METROPOLIS's revenue (11.7% per year) is forecast to grow faster than the Indian market (10.6% per year).
High Growth Revenue: METROPOLIS's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: METROPOLIS's Return on Equity is forecast to be high in 3 years time (21.2%)